Xcout Intel
Cytospire Therapeutics
Cytospire Therapeutics Limited is a biotechnology research company based in London, United Kingdom. The company is focused on developing a portfolio of next-generation immune cell engagers to improve patients' lives.
Subscribe to see Cytospire Therapeutics’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Cytospire Therapeutics at a glance
Cytospire Therapeutics is a life sciences company headquartered in United Kingdom, founded in 2023. Its most recent funding round, Series A, raised $83M in May 2026. Xcout tracks 6 named people at Cytospire Therapeutics, including Natalie Mount (Chief Executive Officer, Board Director).
Cytospire Therapeutics leadership
- Natalie MountChief Executive Officer, Board Director
- Andrew FaddenChief Business Officer
- Peter GoodfellowNon-Executive Chair
- Alexis VandierNon-Executive Director, Servier Ventures
- Casper BreumNon-Executive Director, Sound Bioventures
- Samit HirawatNon-Executive Director
Cytospire Therapeutics funding rounds
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Series A | $83M | 11 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Investors
Cytospire Therapeutics competitors
A few of Cytospire Therapeutics's closest competitors — see the full list of competitors and alternatives →
CytoImmune Therapeutics is a clinical-stage biotechnology company headquartered in Duarte, California, focused on developing novel cell therapies for cancer treatment.
Centauri Therapeutics Limited is a privately held immunotherapy company with its primary headquarters located in London, United Kingdom.
Pheon Therapeutics is a biotechnology research company headquartered in London, England, that specializes in developing next-generation antibody-drug conjugates for hard-to-treat cancers.
CytoSite BioPharma Inc. is a biotechnology company located in Boston, Massachusetts, engaged in commercial physical and biological research and development.
Century Therapeutics is an innovative biotechnology company headquartered in Philadelphia, Pennsylvania. Its mission is to develop allogeneic, iPSC-derived NK and T cell therapies that are designed to be more effective, tolerable, and accessible.
Get Cytospire Therapeutics's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Cytospire Therapeutics in Xcout Intel
- 6 named people with titles, LinkedIn and board committees
- 1 funding round with the investors in each, and who they co-invest with
- The full competitor set, tracking, exports and API access